Paul is new CEO at EvaluatePharma

Share this article:

EvaluatePharma named Debbie Paul to the position of CEO Americas, EvaluatePharma USA, effective immediately.

In the new post, Paul is leading the data analysis and forecasting firm's North American operations and its strategic expansion into Canada and Latin America. Jonathan de Pass remains as chief executive of the UK-based parent company, EvaluatePhar­ma Ltd., which he founded.

Paul has been with the firm since 2004, most recently serving as SVP, North America, and has 25 years of healthcare and life science industry experience, ranging from being a critical-care nurse manager to directing market research for Sandoz.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Read the complete April 2014 Digital Edition

Read the complete April 2014 Digital Edition

Click the above link to access the complete Digital Edition of the April 2014 issue of MM&M, with all text, charts and pictures.

Antidote: Are e-cigarettes safe?

Antidote: Are e-cigarettes safe?

The pros and cons of e-cigarettes

Combating concept churn

Combating concept churn

There's no cure. But the good news is that prophylaxis is possible.